IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) VERSUS MELPHALAN-PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY
San-Miguel, J.1; Schlag, R.2; Khuageva, N.3; Dimopoulos, M.4; Shpilberg, O.5; Kropff, M.6; Spicka, I.7; Petrucci, M.8; Palumbo, A.9; Samoilova, O.10; Dmoszynska, A.11; Abdulkadyrov, K.12; Schots, R.13; Jiang, B.14; Mateos, M.1; Anderson, K.15; Esseltine, D.; Liu, K.16; Cakana, A.17; Van de Velde, H.17; Richardson, P.15
刊名HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
2008-06-01
93页:192-193
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
语种英语
WOS记录号WOS:000263430200474
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63153
专题北京大学第二临床医学院
北京大学药学院_药事管理与临床药学系
作者单位1.Hosp Univ Salamanca, Salamanca, Spain
2.Praxisklin Dr Schlag, Wurzburg, Germany
3.SP Botkin Moscow City Clin Hosp, Moscow, Russia
4.Univ Athens, Sch Med, GR-11527 Athens, Greece
5.Rabin Med Ctr, Petah Tiqwa, Israel
6.Univ Munster, Munster, Germany
7.Univ Hosp, Prague, Czech Republic
8.Univ Roma La Sapienza, Rome, Italy
9.Univ Turin, Turin, Italy
10.Nizhnii Novgorod Reg Clin Hosp, Novgorod, Russia
11.Med Univ Lublin, Lublin, Poland
12.St Petersburg Clin Res Inst Hematol & Transfusiol, St Petersburg, Russia
13.Belgian Hematol Soc, Myeloma Study Grp, Brussels, Belgium
14.Peking Univ, Peoples Hosp, Beijing, Peoples R China
15.Dana Farber Canc Inst, Boston, MA 02115 USA
16.Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium
17.Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
推荐引用方式
GB/T 7714
San-Miguel, J.,Schlag, R.,Khuageva, N.,et al. SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) VERSUS MELPHALAN-PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,2008,93:192-193.
APA San-Miguel, J..,Schlag, R..,Khuageva, N..,Dimopoulos, M..,Shpilberg, O..,...&Richardson, P..(2008).SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) VERSUS MELPHALAN-PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY.HAEMATOLOGICA-THE HEMATOLOGY JOURNAL,93,192-193.
MLA San-Miguel, J.,et al."SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) VERSUS MELPHALAN-PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY".HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93(2008):192-193.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[San-Miguel, J.]的文章
[Schlag, R.]的文章
[Khuageva, N.]的文章
百度学术
百度学术中相似的文章
[San-Miguel, J.]的文章
[Schlag, R.]的文章
[Khuageva, N.]的文章
必应学术
必应学术中相似的文章
[San-Miguel, J.]的文章
[Schlag, R.]的文章
[Khuageva, N.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。